Mr. Leon Recanati
Chairman of The Investment Committee
Mr. Recanati is one of Israel's premier business figures and is currently the Chairman and CEO of GlenRock Israel. Prior to founding GlenRock in 2003, he served as Chairman and CEO of IDB Holding Corporation Ltd., one of the largest investment companies in Israel; Chairman of Clal Industries and Investments Ltd.; and Chairman of Azorim Investment Development and Construction Ltd. Until 1997, Mr. Recanati was Chairman of Delek Israel Fuel Corporation and Chairman of Super-Sol (a leading Israeli retail corporation), in addition to holding several other positions at a variety of operating companies in Israel.
Mr. Efi Cohen-Arazi
Mr. Cohen-Arazi has over 20 years of experience in the medical and biotech industries involving executive management responsibility for both development and business. Prior to establishing Rainbow Medical, Mr. Cohen-Arazi served as CEO of IntecPharma, Israel, a company specializing in drug development and delivery. Previously, Mr. Cohen-Arazi was V.P. Corporate Manufacturing, Head of Contract Manufacturing and Site Head at U.S.-based Amgen Corporation, where he established and led several global strategic partnerships to develop and manufacture small molecules and biopharmaceuticals. Mr. Cohen-Arazi held senior positions at Immunex in the U.S. and at the Merck-Serono Group in Switzerland. Mr. Cohen-Arazi holds advanced degrees in Agriculture and Microbiology from the Hebrew University of Jerusalem.
Mr. Boris Kalandar
Mr. Kalandar is the founder of SVM Advisors, LLC, a 15-year-old boutique technology merchant bank, and SVM-Israel investment funds. He is also a co-founder of MentorTech Ventures, a top quartile VC firm focusing on University of Pennsylvania related companies. He is a former senior executive with SMG, Inc., which was named three times to the “Inc. 500” fastest growing companies list, and led its $50M private equity re-capitalization exit. Mr. Kalandar is an investment advisor to Ben Franklin Technology Partners and a board member of various med-tech companies, including NeuroDx, Eye-IC, Soft Tissue Regeneration, and Syntezza Molecular Detection.
Mr. Yossi Gross
Mr. Gross is a medical device industry visionary and one of its most experienced and successful entrepreneurs. Mr. Gross has founded or co-founded 27 medical device companies, providing innovative solutions to significant unmet medical needs, and has over 500 patent applications in his name.
Mr. Ziv Kop
With over a decade of management experience and polished expertise in strategic planning and business development, Ziv Kop is a Managing Partner at GlenRock, and leads business and strategy development for GlenRock and its portfolio companies. Prior to that, Ziv was the General Manager of POC Management Consulting, a leading Israeli consultancy in the field of strategic planning. Ziv has been involved in more than 100 market-driven strategic planning processes for top executives in diverse fields – from consumer goods to hi-tech, from telecommunications to retailing. A graduate of Tel Aviv University Law School and Business School (with distinction), Ziv also completed the prestigious intensive one-month INSEAD Young Managers Program. In 2003, Ziv was ranked among the ten most promising young managers by Israeli business magazine "The Marker" and in 2009 as one of the "40 promising executives under 40" prestigious list.
Mr. Ori Elan
Mr. Elan took a leading role in founding Real Imaging, a medical device company which has created a comprehensive imaging solution for breast cancer detection. He currently serves as Executive Director of Real Imaging and is responsible for its equity financing transactions. Previously, Mr. Elan served as a Senior Consultant for POC, a company specializing in business strategy, programs, processes and projects. Mr. Elan has also founded a multinational medical device company with significant sales from the design and manufacture of a device to alleviate back pain. Since 2006 Mr. Elan has additionally been active in international real estate ventures.
